Highlights:
- Gestational diabetes significantly increases the risk of complications during pregnancy.
- A new study has linked gut microbiota dysbiosis to the onset and progression of gestational diabetes.
- Early detection and intervention can help reduce pregnancy complications.
Washington, D.C.—A new study has identified early-pregnancy gut microbiota signatures associated with the development of gestational diabetes mellitus, a metabolic disorder that carries substantial risks to both maternal and fetal health. The study, published in the American Society for Microbiology journal Microbiology Spectrum, provides new avenues for gestational diabetes prevention and management.
Gestational diabetes is a prevalent metabolic disorder characterized by abnormal glucose metabolism, primarily in the mid to late stages of pregnancy. Early intervention for gestational diabetes can substantially reduce complications for both mother and baby. Gestational diabetes significantly increases the risk of maternal complications such as gestational hypertension, polyhydramnios, and cesarean delivery, while also posing long-term health risks for the fetus, including asphyxia at birth and increased susceptibility to obesity and diabetes in adulthood.
In the new study, researchers from The Second Hospital, Southern Medical University, and the Third Affiliated Hospital of Guangzhou Medical University, all in Guangzhou, China, set out to identify gut microbiota dysbiosis that is strongly linked to the onset and progression of gestational diabetes that may serve as a critical early-warning biomarker. The scientists analyzed the fecal microbiota of 61 pregnant women during their first trimester of pregnancy using 16S rRNA sequencing. They then correlated these microbial profiles with oral glucose tolerance test results at 24-28 weeks of gestation and clinical delivery outcomes.
The researchers discovered that there were significant differences in gut microbiota composition between those with gestational diabetes and women who had healthy pregnancies. Based on their findings, the researchers developed an early diagnostic model for gestational diabetes, based on genus-level markers, with high diagnostic precision.
“These findings suggest that microbiota-based tools could enable early, non-invasive detection of gestational diabetes mellitus, offering new opportunities for prevention and personalized management,” write the study authors. “This research highlights the role of the gut microbiome in pregnancy and has important implications for improving maternal and fetal health outcomes.”
###
The American Society for Microbiology is one of the largest professional societies dedicated to the life sciences and is composed of over 37,000 scientists and health practitioners. ASM's mission is to promote and advance the microbial sciences.
ASM advances the microbial sciences through conferences, publications, certifications, educational opportunities and advocacy efforts. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to all audiences.
Journal
Microbiology Spectrum